FDA Approves Pfizer Cancer Drug For Dogs

June 3, 2009 by

The Food and Drug Administration (FDA) have just approved a drug called Palladia for the treatment of cancer in dogs.

The drug is manufactured by a division of Pfizer Inc, and is the first ever drug developed specifically for canine cancer.

The drug is approved to treat dogs with a type of skin cancer known as Canine mast cell tumors.

Before the development of this drug, all previous drugs to treat cancer in dogs were initially developed for humans battling the disease.

According to Pfizer, they hope to begin selling Palladia sometime next year.

Comments are closed.